Saturday 17 October 2026
Export AIRS’s income statement to Excel — free account
AirSculpt Technologies, Inc.
AIRS Healthcare Medical Care Facilities
AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 2.53%, EPS fell 57.0%, free cash flow fell 131.1% and total debt fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.28
0.14
−9.86%
Follow AIRS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.81 | 33.81 | — |
Piotroski F-Score |
3 | 3 | 6 | 4 | 6 | — | — | — |
Altman Z-Score |
0.95 | 1.90 | 3.08 | 1.58 | 5.90 | — | — | — |
P/S ratio |
0.79 | 1.66 | 2.08 | 1.22 | 7.17 | 7.45 | 7.45 | — |
Altman Z″-Score (non-manufacturers) |
(0.63) | (0.25) | 0.60 | (0.01) | 1.70 | — | — | — |
P/FCF ratio |
172.97 | 0.00 | 29.08 | 17.92 | 49.01 | 23.34 | 23.34 | — |
P/Operating CF |
(47.29) | 110.36 | 83.90 | 31.11 | (167.62) | 103.71 | 103.71 | — |
Beneish M-Score |
(3.34) | (2.34) | (3.30) | — | — | — | — | — |
P/B ratio |
1.36 | 3.83 | 4.86 | 2.92 | 11.45 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
1.10 | 2.03 | 2.40 | 1.66 | 7.60 | 8.31 | 8.31 | — |
EV/EBITDA |
137.01 | 35.50 | 23.51 | 79.78 | 45.33 | 24.27 | 24.27 | — |
EV/Operating CF |
54.03 | 32.24 | 19.60 | 11.47 | 38.06 | 21.29 | 21.29 | — |
EV/FCF |
241.75 | (137.70) | 33.45 | 24.34 | 51.94 | 26.02 | 26.02 | — |
Quick Ratio |
0.36 | 0.39 | 0.60 | 0.56 | 1.54 | 1.10 | 0.61 | — |
Current Ratio |
0.55 | 0.59 | 0.79 | 0.75 | 1.79 | 1.22 | 0.79 | — |
Net Debt/EBITDA |
38.98 | 6.45 | 3.07 | 21.03 | 2.56 | 1.41 | 4.90 | — |
Debt/Assets |
29.92% | 35.11% | 35.11% | 41.61% | 41.19% | 18.11% | 19.07% | 0.00% |
Debt/Equity |
0.64 | 0.96 | 0.85 | 1.18 | 0.99 | 0.26 | 0.27 | — |
Asset Turnover |
0.76 | 0.87 | 0.97 | 0.84 | 0.70 | 0.36 | 0.48 | — |
Operating CF/Net income |
(0.27) | (1.42) | (5.65) | (1.67) | (67.77) | 1.84 | (2.23) | — |
Capex/Depreciation |
(0.19) | (1.18) | (0.97) | (1.60) | (1.08) | (0.65) | (0.89) | — |
Interest Coverage |
(1.90) | (0.25) | 1.50 | (0.67) | 3.23 | 4.09 | 0.23 | — |
| (14.07%) | (9.89%) | (5.48%) | (19.03%) | (0.38%) | 6.21% | (1.81%) | — | |
| (5.83%) | (3.85%) | (2.09%) | (7.32%) | (0.21%) | 4.32% | (2.58%) | — | |
ROIC |
(5.34%) | (0.68%) | 4.18% | (1.96%) | 7.00% | 4.30% | 0.28% | — |
Return on Tangible Assets |
(75.92%) | (31.27%) | (17.27%) | (79.07%) | (1.47%) | 82.23% | (87.09%) | — |
Average Days of Receivables |
3.60 | 6.18 | 3.62 | 6.12 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
54.13% | 54.83% | 52.26% | 60.08% | 49.31% | 37.63% | 48.80% | — |
Intangible Assets out of Total Assets |
0.63 | 0.58 | 0.63 | 0.66 | 0.69 | 0.79 | 0.86 | 0.00 |
Share Based Compensation of Revenue |
1.54% | 2.09% | 9.30% | 17.45% | 5.39% | 0.52% | 0.83% | — |
Graham Net Nets |
(0.70) | (0.39) | (0.25) | (0.55) | (0.09) | (0.12) | (0.12) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(9.60%) | (2.89%) | (1.12%) | (7.01%) | (0.17%) | 2.96% | 2.96% | — |
Free Cash Flow Yield |
0.58% | (0.89%) | 3.44% | 5.58% | 2.04% | 4.28% | 4.28% | — |
Revenue per Share |
2.51 | 3.13 | 3.45 | 3.03 | 2.40 | 1.13 | 0.74 | — |
Operating CF per Share |
0.05 | 0.20 | 0.42 | 0.44 | 0.48 | 0.25 | 0.09 | — |
Capex per Share |
(0.04) | (0.24) | (0.17) | (0.23) | (0.13) | (0.07) | (0.08) | — |
Free Cash Flow per Share |
0.01 | (0.05) | 0.25 | 0.21 | 0.35 | 0.18 | 0.01 | — |
Cash per Share |
0.14 | 0.14 | 0.18 | 0.17 | 0.46 | 0.19 | 0.09 | — |
Shareholders Equity per Share |
1.45 | 1.36 | 1.48 | 1.27 | 1.50 | 2.22 | 2.16 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.45 | 1.36 | 1.48 | 1.27 | 1.50 | 2.22 | 2.16 | — |
Free Cash Flow |
0.69 | (2.66) | 14.04 | 11.53 | 19.52 | 10.27 | 0.50 | — |
Working Capital |
(12.45) | (11.83) | (4.35) | (5.64) | 13.03 | 2.11 | (1.77) | — |
Capital Expenditures |
(2.40) | (14.01) | (9.92) | (12.92) | (7.12) | (3.69) | (4.44) | — |
Net Current Asset Value |
(84.14) | (117.48) | (104.07) | (113.32) | (87.59) | (44.37) | (44.52) | — |
EV/EBIT |
0.00 | 0.00 | 48.30 | 0.00 | 64.29 | 0.00 | 0.00 | — |
Capex to Sales |
0.02 | 0.08 | 0.05 | 0.08 | 0.05 | 0.06 | 0.11 | — |
Price to Operating Income |
0.00 | 0.00 | 41.99 | 0.00 | 60.66 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.46 | 0.32 | 0.35 | 0.33 | 0.48 | 0.79 | 1.15 | — |
Cash ROIC |
0.45% | (1.65%) | 8.46% | 7.03% | 10.19% | 6.16% | 0.32% | — |
Accounts Receivable Turnover |
66.66 | 72.18 | 82.11 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
10.61 | 13.98 | 19.00 | 19.28 | 23.66 | 14.63 | 9.65 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
31.76 | 32.09 | 19.40 | 22.35 | 21.88 | 17.03 | 49.82 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
2.28 | 2.50 | 2.39 | — | — | — | — | — |
Average Payables |
5.81 | 5.09 | 3.88 | 3.26 | 1.88 | 1.60 | 1.60 | — |
Average Assets |
200.04 | 208.40 | 202.39 | 200.66 | 190.08 | 175.56 | 85.75 | — |
Average Common Equity |
82.95 | 81.09 | 77.38 | 77.15 | 103.60 | 122.03 | 122.03 | — |
Columns are period end dates